Study shows Cannabis terpenes may relieve chemotherapy-induced neuropathic pain

Study shows Cannabis terpenes may relieve chemotherapy-induced neuropathic pain: Study shows Cannabis terpenes may relieve chemotherapy-induced neuropathic pain

Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">

Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">

Cannabis Industry Applauds President Biden's Commitment to Reschedule Marijuana During Annual Visit to Capitol Hill

Cannabis Industry Applauds President Biden's Commitment to Reschedule Marijuana During Annual Visit to Capitol Hill: Cannabis Industry Applauds President Biden's Commitment to Reschedule Marijuana During Annual Visit to Capitol Hill

Cannabis Stocks Run on Department of Justice News (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Cannabis Stocks Run on Department of Justice News (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB): Cannabis Stocks Run on Department of Justice News (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Run Continues

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Run Continues: Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Run Continues

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX Volume Leaders

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX Volume Leaders: Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX Volume Leaders

Follow the Money in Pot Stocks - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) Gains on Record Quarterly Net Revenue

Follow the Money in Pot Stocks - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) Gains on Record Quarterly Net Revenue: Follow the Money in Pot Stocks - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) Gains on Record Quarterly Net Revenue

Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III

Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III: Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III

Cannabis Stocks in Play - IM Cannabis Corp. (NASDAQ: IMCC) Makes NASDAQ Top Gainers List

Cannabis Stocks in Play - IM Cannabis Corp. (NASDAQ: IMCC) Makes NASDAQ Top Gainers List: Cannabis Stocks in Play - IM Cannabis Corp. (NASDAQ: IMCC) Makes NASDAQ Top Gainers List

Cannabis Stocks in Play - Tilray Brands, Inc. (NASDAQ: TLRY) Flies on Company News and Possible DEA Reclassification of Marijuana

Cannabis Stocks in Play - Tilray Brands, Inc. (NASDAQ: TLRY) Flies on Company News and Possible DEA Reclassification of Marijuana: Cannabis Stocks in Play - Tilray Brands, Inc. (NASDAQ: TLRY) Flies on Company News and Possible DEA Reclassification of Marijuana

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) Makes Top Traders List and Top Percentage Gainers List on TSX

Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) Makes Top Traders List and Top Percentage Gainers List on TSX: Pot Stocks in Play - Canopy Growth Corporation (TSX: WEED) Makes Top Traders List and Top Percentage Gainers List on TSX

April Wrap Up- Stocks to Watch (NASDAQ: $PXMD) (Nasdaq: $RLYB) (NASDAQ: $CYN) (NASDAQ: $MSGM)

  April Wrap Up- Stocks to Watch (NASDAQ: $PXMD) (Nasdaq: $RLYB) (NASDAQ: $CYN) (NASDAQ: $MSGM)

 

Stocks to Watch in Biotech, Cannabis, Green, eSport and Tech- (NASDAQ: $AVTX) (NASDAQ: $AKAN) (NASDAQ: $VVPR) (NASDAQ: $RENT)

 

 

 

April 29, 2024 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Biotech, Cannabis, Green, eSport and Tech sectors.  

 

Read this in full at https://www.investorideas.com/news/2024/main/04291Stocks.asp

 

This week’s new companies are involved in a variety of sectors; biotech companies are involved in treating neurologic disorders, rare diseases and immune dysregulation, and the latest cannabis company is also looking to enter the AI and blockchain sectors.

 

The newest green company provides global sustainable energy solutions, while the latest eSport company is a racing game developer, publisher and esports ecosystem provider.

 

The newest tech companies are involved in providing a “Closet in the Cloud” for the fashion industry and autonomous vehicle technology, respectively.

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Biotech Directories:

PaxMedica, Inc. (NASDAQ:PXMD) is a forward-looking clinical-stage biopharmaceutical firm specializing in cutting-edge anti-purinergic drug therapies (APT) aimed at addressing a range of challenging neurologic disorders. Our comprehensive portfolio encompasses a spectrum of conditions, including neurodevelopmental disorders such as Autism Spectrum Disorder (ASD), as well as other critical areas within the neurology field. Additionally, we intend to provide the rest of the world with an additional, reliable source of suramin, the accepted standard of care for Stage 1, Trypanosoma Brucei Rhodesiense. We are dedicated to the continuous development and evaluation of our pioneering program, PAX-101, an intravenous suramin formulation that lies at the heart of our efforts, particularly focused on innovative ASD treatment solutions. Our ongoing research initiatives not only prioritize the needs of ASD patients, but also extend to exploring potential therapeutic applications for related conditions.

 

Rallybio Corporation (Nasdaq: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development. Rallybio is headquartered in New Haven, Connecticut.

 

Avalo Therapeutics, Inc. (NASDAQ:AVTX) is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Avalo’s pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

 

New Stocks Added to the Cannabis Directories:

Akanda Corp. (NASDAQ: AKAN) is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

 

New Stocks Added to the Green Directories:

VivoPower International PLC (NASDAQ: VVPR) is an award-winning global sustainable energy solutions B Corporation company focused on electric solutions for customised and ruggedised fleet applications, battery and microgrids, solar and critical power technology and services. The Company’s core purpose is to provide its customers with turnkey decarbonisation solutions that enable them to move toward net-zero carbon status. VivoPower has operations and personnel in Australia, Canada, the Netherlands, the United Kingdom, the United States, the Philippines, and the United Arab Emirates.

 

New Stocks Added to the eSport Directories:

Motorsport Games Inc. (NASDAQ: MSGM) a Driven Lifestyle Group company, is a racing game developer, publisher and esports ecosystem provider of official motorsport racing series. Combining innovative and engaging video games with exciting esports competitions and content for racing fans and gamers, Motorsport Games strives to make racing games that are authentically close to reality. The Company is the officially licensed video game developer and publisher for iconic motorsport racing series including the 24 Hours of Le Mans and the FIA World Endurance Championship, recently releasing Le Mans Ultimate in Early Access. Motorsport Games also owns the industry leading rFactor 2 and KartKraft simulation platforms. rFactor 2 also serves as the official sim racing platform of Formula E, while also powering F1 Arcade through a partnership with Kindred Concepts. Motorsport Games is also an award-winning esports partner of choice for the 24 Hours of Le Mans, creating the renowned Le Mans Virtual Series. Motorsport Games is building a virtual racing ecosystem where each product drives excitement, every esports event is an adventure, and every race inspires.

 

New Stocks Added to the Tech Directories:

Cyngn Inc. (NASDAQ: CYN) develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Cyngn's self-driving solutions allow existing workforces to increase productivity and efficiency. The Company addresses significant challenges facing industrial organizations today, such as labor shortages, costly safety incidents, and increased consumer demand for eCommerce. Cyngn's DriveMod Kit can be installed on new industrial vehicles at end of line or via retrofit, empowering customers to seamlessly adopt self-driving technology into their operations without high upfront costs or the need to completely replace existing vehicle investments. Cyngn's flagship product, its Enterprise Autonomy Suite, includes DriveMod (autonomous vehicle system), Cyngn Insight (customer-facing suite of AV fleet management, teleoperation, and analytics tools), and Cyngn Evolve (internal toolkit that enables Cyngn to leverage data from the field for artificial intelligence, simulation, and modeling).

 

Rent the Runway, Inc. (NASDAQ: RENT) is disrupting the trillion-dollar fashion industry and changing the way women get dressed through the Closet in the Cloud, the world’s first and largest shared designer closet. RTR’s mission has remained the same since its founding: powering women to feel their best every day. Through RTR, customers can subscribe, rent items a-la-carte and shop resale from hundreds of designer brands. The Closet in the Cloud offers a wide assortment of millions of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear and ski wear. RTR has built a two-sided discovery engine, which connects deeply engaged customers and differentiated brand partners on a powerful platform built around its brand, data, logistics and technology. Under CEO and Co-Founder Jennifer Hyman’s leadership, RTR has been named to CNBC’s “Disruptor 50” five times in ten years, and has been placed on Fast Company’s Most Innovative Companies list four times, while Hyman herself has been named to the "TIME 100: Most Influential People in the World" and as one of People Magazine’s “Women Changing the World."

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB): You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Cannabis Stock News Bite - Tilray Brands (Nasdaq: TLRY) (TSX: TLRY) Stock Trends on 420

Cannabis Stock News Bite - Tilray Brands (Nasdaq: TLRY) (TSX: TLRY) Stock Trends on 420: Cannabis Stock News Bite - Tilray Brands (Nasdaq: TLRY) (TSX: TLRY) Stock Trends on 420

Cannabis Stock News Bite - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) Gains on Florida Ballot to legalize Recreational Cannabis

Cannabis Stock News Bite - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) Gains on Florida Ballot to legalize Recreational Cannabis: Cannabis Stock News Bite - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) Gains on Florida Ballot to legalize Recreational Cannabis

Crypto Stocks off - Cannabis Stocks on (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Crypto Stocks off - Cannabis Stocks on (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB): Crypto Stocks off - Cannabis Stocks on (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Cannabis Stock News: New Leader in German Cannabis Created with Acquisition of TruHC, Leading EU-GMP Medical Cannabis Producing Facility, on Historic Day Germany Legalizes Recreational Cannabis

Cannabis Stock News: New Leader in German Cannabis Created with Acquisition of TruHC, Leading EU-GMP Medical Cannabis Producing Facility, on Historic Day Germany Legalizes Recreational Cannabis: Cannabis Stock News: New Leader in German Cannabis Created with Acquisition of TruHC, Leading EU-GMP Medical Cannabis Producing Facility, on Historic Day Germany Legalizes Recreational Cannabis

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB): Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Cannabis Stock News Bite - Traders Jump Back into Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC)

Cannabis Stock News Bite - Traders Jump Back into Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC): Cannabis Stock News Bite - Traders Jump Back into Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC)

The Hunt for Penny Cannabis Stocks (TSX: DN.TO) (OTC: DLTNF) (TSX: XLY.TO) (OTCQB: CBWTF)

The Hunt for Penny Cannabis Stocks (TSX: DN.TO) (OTC: DLTNF) (TSX: XLY.TO) (OTCQB: CBWTF): The Hunt for Penny Cannabis Stocks (TSX: DN.TO) (OTC: DLTNF) (TSX: XLY.TO) (OTCQB: CBWTF)

Cannabis Stock News Bite - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) Continues Rally with Gains of over 30%

Cannabis Stock News Bite - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) Continues Rally with Gains of over 30%: Cannabis Stock News Bite - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) Continues Rally with Gains of over 30%

Pot Stocks on the Run - (NASDAQ: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Pot Stocks on the Run - (NASDAQ: CGC) (NASDAQ: TLRY) (NASDAQ: ACB): Pot Stocks on the Run - (NASDAQ: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Cannabis Stock News Bite - Pot Stock Canopy Growth (TSX: WEED) (Nasdaq: CGC) on the Run Again

Cannabis Stock News Bite - Pot Stock Canopy Growth (TSX: WEED) (Nasdaq: CGC) on the Run Again: Cannabis Stock News Bite - Pot Stock Canopy Growth (TSX: WEED) (Nasdaq: CGC) on the Run Again

Cannabis Stock News Bite - Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY) Gains in Morning Trading

Cannabis Stock News Bite - Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY) Gains in Morning Trading: Cannabis Stock News Bite - Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY) Gains in Morning Trading

Cannabis Stock News Bite - Investors High on Cannabis Stock Gains - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) up over 20%

Cannabis Stock News Bite - Investors High on Cannabis Stock Gains - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) up over 20%: Cannabis Stock News Bite - Investors High on Cannabis Stock Gains - Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) up over 20%

Cannabis Stock News Bite - Curaleaf Holdings (TSX: CURA) Gives Struggling Cannabis Stocks a Win on News

Cannabis Stock News Bite - Curaleaf Holdings (TSX: CURA) Gives Struggling Cannabis Stocks a Win on News: Cannabis Stock News Bite - Curaleaf Holdings (TSX: CURA) Gives Struggling Cannabis Stocks a Win on News

Cannabis Stock News Bite - Incannex (NASDAQ: IXHL) Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorde

Cannabis Stock News Bite - Incannex (NASDAQ: IXHL) Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorde: Cannabis Stock News Bite - Incannex (NASDAQ: IXHL) Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Revolution Cannabis Workers Ratify Contract With Teamsters Local 777

Revolution Cannabis Workers Ratify Contract With Teamsters Local 777: Revolution Cannabis Workers Ratify Contract With Teamsters Local 777

Breaking CBD News: Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences (OTCQB: $PBIO) UltraShear Processing for Revolutionary Product Effectiveness; @ir_pressurebio @UncleBuds_Hemp

 

Breaking CBD News: Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences (OTCQB: $PBIO) UltraShear Processing for Revolutionary Product Effectiveness; @ir_pressurebio @UncleBuds_Hemp

 

Multi-Patented Nanoemulsification Platform Enables Wide-Range of Best-in-Class Health and Wellness Products - Revenue Impact of $5 Million in 2024 Anticipated with Further Acceleration in 2025 & Beyond

 

Pressure BioSciences February 5th Investor Call to Discuss Impact of Recent Uncle Bud's Acquisition

 

SOUTH EASTON, Mass. - February 5, 2024 (Investorideas.com Newswire) Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is hosting a teleconference today (Monday, February 5th, 4:30PM EST) to discuss the recent acquisition of natural health and wellness innovator Uncle Bud's ("UB"), as well as other on-going opportunities.

 

Read this in full at https://www.investorideas.com/news/2024/cannabis/02051PBIO-CBD-Body-Revive-Spray.asp

 

CBD Body Revive Spray

 

CBD Body Revive Spray All Natural, Fast Acting, Plant Based, Preservative Free, Best-in-Class, UltraShear-processed Nano CBD

...the first in a series of groundbreaking premium nanoemulsified products designed to meet the needs of consumers looking for the highest quality and performance in natural and effective wellness solutions. Click here for more info on Uncle Bud's Premium Collection.

In an exciting leap forward for natural wellness enthusiasts, Uncle Bud's Health and Wellness ("Uncle Bud's") is announcing the planned launch of its UltraShear-processed "Premium Collection" of state-of-the-art nanoemulsified products. The collection, highlighted by its flagship product - the CBD Body Revive Spray with 1200mg of Nano CBD - will be processed with PBIO's multi-patented UltraShear Technology™ (UltraShear™ or UST™), and is expected to redefine the standards of effectiveness and quality in CBD and other products. These products represent the pinnacle of innovation, quality, and commitment to natural, clean wellness solutions. The Premium Collection launch is expected on or before March 1, 2024.

 

Developed in collaboration with scientists from Uncle Bud's parent PBIO, the UltraShear-processed Premium Collection stands as a testament to Uncle Bud's dedication to harnessing the power of science to amplify the benefits of natural ingredients. By utilizing cutting-edge UltraShear Technology, Premium Collection products will offer unparalleled speed of absorption and delivery of active ingredient dosing payload more efficiently - for faster, more effective results.

 

Embodying Uncle Bud's commitment to safety and environmental responsibility, all UltraShear Premium Collection products will be crafted from 100% natural, clean ingredients, and GMO-free. This meticulous attention to detail guarantees customers receive the highest quality, most sustainable products available for integrating into their daily wellness routines.

 

For the launch of the new premium products, Uncle Bud's is inaugurating a new website category dedicated exclusively to the innovation and quality of the Premium Collection product line. The launch of the initial product - CBD Body Revive Spray with 1200 mg of Nano CBD for powerful, fast-acting relief in a convenient spray form - offers an essential addition in any wellness regimen and marks the beginning of a series of groundbreaking premium products designed to meet the needs of consumers looking for the highest quality and performance in natural and effective wellness solutions.

 

"We are incredibly excited to introduce the UltraShear-processed Premium Collection of innovative, nanoemulsified products to our customers," said Bruno Schiavi, President of Uncle Bud's. "This is a major milestone for us, combining the best of science and nature to create a product line that not only meets but sets a new benchmark for the highest standards of quality, purity, and effectiveness." Click here for more info on Uncle Bud's Premium Collection.

 

John Hollister, PBIO's Director of Sales and Marketing, added: "What an exciting time for all stakeholders in PBIO. With revenues of $5 million anticipated from Uncle Bud's in 2024, combined with revenues of $5 million anticipated from historical PBIO products/services, we believe total 2024 revenues could be 5X or more of our historical annual revenue."

 

Teleconference Information (click here for more conference call details)

• Date: Monday, February 5, 2024. 4:30 pm ET (US).
• Call-in Number: 888-267-2918 (code: 973092).

 

About Uncle Bud's

Launched in 2018 with a trailblazing hemp-based Pain Relief product, Uncle Bud's has rapidly captured an innovative leadership role in the Hemp Seed Oil, Cannabidiol (CBD), and the broader Health & Wellness industry. The Uncle Bud's brand is revered for its unwavering commitment to domestic manufacturing excellence, setting benchmarks for its organic, preservative-free, non-GMO standards and its ethical cruelty-free practices. Uncle Bud's is dedicated to the highest-quality formulations and to continuous improvement, guided by the latest scientific research and development innovations - including the revolutionary performance breakthroughs delivered by PBIO's patented UltraShear™ processing platform. Uncle Bud's diverse product portfolio addresses an ever-broadening spectrum of consumer needs, encompassing pain relief, sophisticated skincare solutions, personal wellness and athletic recovery products, and specialized pet care items. Learn More: www.unclebudshemp.com * Follow On Social Media: @UncleBuds_Hemp.

 

Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Our products utilize both constant and alternating pressure. Our patented enabling technology platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterrorism applications. We have recently expanded our market opportunities with the acquisition of the BaroFold™ patented technology platform, allowing us to enter the bio-pharma contract services and GMP manufacturing equipment sector. We have also developed the scalable and high-efficiency pressure-based UltraShear Technology™ (UltraShear™) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. Our commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to our customers.

 

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

 

For more information about PBIO, Uncle Bud's, and this press release, please click on the following website links:
http://www.pressurebiosciences.com www.unclebudshemp.com

Please visit us on Facebook, LinkedIn, and Twitter.

 

Press Contacts

Richard T. Schumacher, President & CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman (650) 812-8121 (T)
Bruno Schiavi, President, PBIO Consumer Products (508) 230-1828 (T)

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: this news for Pressure BioSciences, Inc. (PBIO) is paid for content on our site. Disclosure More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

 

About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Breaking CBD News: Pressure BioSciences (OTCQB: $PBIO) Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds

  

Breaking CBD News: Pressure BioSciences (OTCQB: $PBIO) Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds

Uncle Bud's 2024 Revenue Expected to Increase 3-Fold to Approximately $5 Million, Fueled by UltraShear Processed Nanoemulsion Product Introductions and Exciting New Market Opportunities

 

SOUTH EASTON, Mass. - February 1, 2024 (Investorideas.com Newswire) Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics, and more, today announced that the Company will host a teleconference to discuss the recent strategic acquisition of natural health and wellness innovator Uncle Bud's ("UB") in an all-stock transaction. In particular, the Company will discuss its current, in-process move to new, more efficient manufacturing space; the integration plan of the Uncle Bud's team and product offerings into PBIO; and the significant growth expected from new UltraShear processed nanoemulsion products, which are expected to catapult the Company's total revenue by 5X to about $10M in 2024.

Read this news, featuring PBIO in full at https://www.investorideas.com/news/2024/cannabis/02011PBIO-Investor-Call-Recent-Acquisition-Uncle-Buds.asp

 

UltraShear CBD Body Revive Spray

All Natural, Fast Acting, Plant Based, Preservative Free, Best-in-Class Nano CBD

Teleconference Information

• Format: Company presentation followed by Q&A.
• Date: Monday, February 5, 2024. 4:30pm ET (US).
• Call-in Number: 888-267-2918 (code: 973092).
• Replay: PBIO.Replay.020524

Transaction Significance

• Transaction is expected to be immediately accretive and a major accelerator to PBIO's top line revenue growth.
• Combined companies will be positioned to attract new growth investment, rapidly strengthen the balance sheet, accelerate PBIO's path to profitability in 2024, and catalyze PBIO's drive to uplist to NASDAQ/NYSE in 2024.
• UB leadership are experts in branding, spokesperson management, and online/retail multimedia marketing.
• UB will rapidly incorporate PBIO's best-in-class Nano-CBD into renowned and successful CBD product lines.
• Senior management of UB/PBIO plan a dozen new nanoemulsion products for commercial release in 2024.
• UB already markets and sells many products in health & wellness that expand well beyond Hemp and CBD.
• UB continues building ongoing partnership with multi-Grammy award-winning Toni Braxton - highly successful marketing ambassador leaps to embrace combined PBIO/UB as continuing spokesperson.
• UB enjoys strong following for leading hemp and CBD products, in extensive variety of high profile news outlets and magazines online over many years: https://www.unclebudshemp.com/press/.
• UB currently boasts 70+ products, 865K on-line members, and enviable sales channels with leading large retailers.

Expected Financial Impact

• Acquisition combines existing momentum and ready market execution power of Uncle Bud's, with revolutionary product breakthroughs in absorption and speed of action, enabled by PBIO's UltraShear nanoemulsions platform.
• PBIO forecasts Uncle Bud's $1.6 million 2023 revenue tripling to approximately $5 million in 2024.
• PBIO forecasts a 5-fold catapult forward in total Company revenues to approximately $10 million in 2024.

Transaction Terms
Please refer to the Form 8K filed on January 19, 2024.

About Uncle Bud's

Launched in 2018 with a trailblazing hemp-based Pain Relief product, Uncle Bud's has rapidly captured an innovative leadership role in the Hemp Seed Oil, Cannabidiol (CBD), and the broader Health & Wellness industry. The Uncle Bud's brand is revered for its unwavering commitment to domestic manufacturing excellence, setting benchmarks for its organic, preservative-free, non-GMO standards and its ethical cruelty-free practices. Uncle Bud's is dedicated to the highest-quality formulations and to continuous improvement, guided by the latest scientific research and development innovations - including the revolutionary performance breakthroughs delivered by PBIO's patented UltraShear™ processing platform. Uncle Bud's diverse product portfolio addresses an ever-broadening spectrum of consumer needs, encompassing pain relief, sophisticated skincare solutions, personal wellness and athletic recovery products, and specialized pet care items. Learn More: www.unclebudshemp.com * Follow On Social Media: @UncleBuds_Hemp.

Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Our products utilize both constant and alternating pressure. Our patented enabling technology platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterrorism applications. We have recently expanded our market opportunities with the acquisition of the BaroFold™ patented technology platform, allowing us to enter the bio-pharma contract services and GMP manufacturing equipment sector. We have also developed the scalable and high-efficiency pressure-based UltraShear Technology™ (UltraShear™) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. Our commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to our customers.

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBIO, Uncle Bud's, and this press release, please click on the following website links:
http://www.pressurebiosciences.com www.unclebudshemp.com
Please visit us on Facebook, LinkedIn, and Twitter.

Press Contacts

Richard T. Schumacher, President & CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman (650) 812-8121 (T)
Bruno Schiavi, President, PBIO Consumer Products (508) 230-1828 (T)

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: this news for Pressure BioSciences, Inc. (PBIO) is paid for content on our site. Disclosure More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

 

About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Breaking Cannabis Stock News - High Tide (NASDAQ: HITI) (TSXV: HITI) To Open First Canna Cabana Store in Fort McMurray, Alberta

Breaking Cannabis Stock News - High Tide (NASDAQ: HITI) (TSXV: HITI) To Open First Canna Cabana Store in Fort McMurray, Alberta: Breaking Cannabis Stock News - High Tide (NASDAQ: HITI) (TSXV: HITI) To Open First Canna Cabana Store in Fort McMurray, Alberta

Breaking Psilocybin Stock News - Red Light Holland's (CSE: TRIP) (OTCQB: TRUFF) Homogenized Psilocybin Microdosing Capsules Complete Product Specification Document by cGMP Pharma Company

Breaking Psilocybin Stock News - Red Light Holland's (CSE: TRIP) (OTCQB: TRUFF) Homogenized Psilocybin Microdosing Capsules Complete Product Specification Document by cGMP Pharma Company: Breaking Psilocybin Stock News - Red Light Holland's (CSE: TRIP) (OTCQB: TRUFF) Homogenized Psilocybin Microdosing Capsules Complete Product Specification Document by cGMP Pharma Company

Breaking CBD News: Pressure BioSciences (OTCQB: $PBIO) Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales; @ir_pressurebio

  

Breaking CBD News: Pressure BioSciences (OTCQB: $PBIO) Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales; @ir_pressurebio

 

Merged Companies Will Introduce Revolutionary New Product Capabilities Across Multiple Major Market Sectors, Expecting 2024 Revenues of Over $10 Million, Then Accelerating in Future Years

 

 

SOUTH EASTON, Mass. - January 22, 2024 (Investorideas.com Newswire) Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics, and more, today announced the closing of its acquisition of natural health and wellness leader Uncle Bud's ("UB") in an all-stock transaction. Incorporating UB's 70+ already popular products, 865K member on-line community, existing sales channels online and with leading large retailers, enviable celebrity spokesperson relationships, and invaluable experience building successful consumer products businesses, PBIO will leverage and integrate the Company's revolutionary UltraShear™ technology (UltraShear™ or UST™) platform for further improved nanoemulsified products that deliver industry-leading speed of action, effective dosing payload delivery, and long-term stability. With these unique product improvement and differentiation capabilities, PBIO intends to redefine the basis of competition in multiple major market sectors, and to become a leading provider of topicals and other consumer products.

 

Read this news, featuring PBIO in full at https://www.investorideas.com/news/2024/cannabis/01221PBIO-Uncle-Bud-Acquisition-UltraShear-Nanoemulsions.asp

 

Toni Braxton

Multi-award-winning singer, songwriter, actress, and long-term Uncle Bud's advocate and spokesperson.

Transaction Terms

Under the terms of the transaction, PBIO acquired all assets and assumed selected liabilities of UB. In addition, the parties agreed to an earnout for additional shares of PBIO Common Stock based on the achievement of revenue and pre-tax income results in 2024. Upon closing, all employees of UB became employees of PBIO and UB became the Consumer Products Business Unit of PBIO. More definitive transaction terms will be included in the Company's upcoming SEC filings.

 

Significance of the Transaction

• The transaction is expected to be immediately accretive and a major accelerator to PBIO's top line revenue growth.
• The combined companies will be ideally positioned to attract new growth investment, rapidly strengthen their balance sheet, accelerate PBIO's path to profitability in 2024, and catalyze our drive to uplist to NASDAQ/NYSE.
• The co-founders/senior management of UB are experts in branding, celebrity spokesperson management, and online and retail multimedia marketing.
• UB will rapidly incorporate PBIO's best-in-class Nano-CBD into their already highly renowned and successful CBD products, for new market breakaway potential!
• Senior management of UB and PBIO are already planning a dozen new products that they believe could be formulated and released in 2024, just using PBIO's existing UltraShear processed Nano CBD.
• UB markets and sells many products in the health & wellness area that are unrelated to Hemp and CBD.
• UB has an ongoing partnership with multi-Grammy award-winning Toni Braxton as a highly successful marketing ambassador - and Toni has announced that she is excited to continue as a PBIO/UB spokesperson going forward.
• UB has been featured, as well as their hemp and CBD products, in an extensive variety of high profile news outlets and magazines online over the past several years: https://www.unclebudshemp.com/press/.

 

Expected Financial Impact

PBIO's President and CEO, Richard T. Schumacher, summarized: "This transaction combines the existing momentum and ready market execution power of Uncle Bud's with the pivotal scientific and product breakthrough of the UltraShear nanoemulsions processing platform for record-setting product performance and long-term stability. In 2024 alone, we are forecasting a 5-fold leap forward in PBIO revenues to over $10 million, but this is only a steppingstone towards revolutionary impact and sales growth that we expect to achieve across the nutraceuticals, cosmeceuticals, skincare, food/beverage, agrochemical, and other major markets in the following years."

 

Jeffrey N. Peterson, PBIO's Chairman, added: "Our Board and leadership team have carefully sought out this strategic combination of Uncle Bud's marketing skill and power to combine with PBIO's world class scientific innovation team. Specifically, this positions PBIO with a fast forward integration capability that will allow us to selectively set the timing and drive the pace of revolutionary change across multiple major markets. This rapid growth engine provides a central platform to leverage new growth capital, restructure and strengthen our balance sheet, and complete our drive to uplist to a national stock exchange in 2024."

 

About Uncle Bud's

Officially launched in September 2018 with one hero product, Uncle Bud's has experienced unequivocal growth. As a leader in the Hemp and CBD space, Uncle Bud's takes pride in being Made in America, GMO Free, Cruelty Free and Leaping Bunny Certified. The full range includes Hemp & CBD products for pain relief, skincare, personal care, and even pet care - all retailing under $45. To learn more about Uncle Bud's visit unclebudshemp.com as well as their associated Instagram: @UncleBuds_Hemp; Facebook: @UncleBuds_Hemp and Twitter: @UncleBuds_Hemp.

 

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Our products utilize both constant and alternating pressure. Our patented enabling technology platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterrorism applications. We have recently expanded our market opportunities with the acquisition of the BaroFold™ patented technology platform, allowing us to enter the bio-pharma contract services and GMP manufacturing equipment sector. We have also developed the scalable and high-efficiency pressure-based UltraShear Technology™ (UltraShear™) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. Our commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to our customers.

 

Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBIO, Uncle Bud's, and this press release, please click on the following website links:
http://www.pressurebiosciences.com www.unclebudshemp.com

Please visit us on Facebook, LinkedIn, and Twitter.

 

Press Contacts

Richard T. Schumacher, President & CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman (650) 812-8121 (T)
Bruno Schiavi, President, PBIO Consumer Products (508) 230-1828 (T)

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: this news for Pressure BioSciences, Inc. (PBIO) is paid for content on our site. Disclosure More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

 

 Investorideas.com potcasts - Listen to Investor Ideas Potcasts Cannabis News and Stocks on the Move

 

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks plus the new psychedelic stock directory

 

 

Follow Pot stocks news - Get News Alerts on Marijuana Stocks

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp